DEXCOM (DXCM) Files Form 144 on May 15, 2023
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowOn May 15, 2023, Dexcom (DXCM) filed a Form 144 with the SEC. This form is typically used to notify the SEC of a proposed sale of stock by an affiliate. The specific details regarding the number of shares to be sold or the price were not disclosed. Such filings can indicate potential changes in stock ownership that may impact market perceptions and trading activity.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About DexCom Inc. (DXCM)
DexCom makes continuous glucose-monitoring systems for diabetes.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier DXCM news
- DexCom (DXCM) Trading at $64.62 with P/E Ratios 30.92 and 25.91
- Dexcom (DXCM) EVP Brown Sells $107K in Shares
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
